BAG2 and neoplasm: As we already demonstrated that BAG2 expression in the tumor cytoplasm is associated with a reduced recurrence-free survival or breast cancer-specific survival, our findings have a novelty that the addition of BAG2 evaluation in tumor stroma could lead to better estimation of the risk of metastasis in breast cancer [8].